Literature DB >> 1350571

IgG subclass responses to Theiler's murine encephalomyelitis virus infection and immunization suggest a dominant role for Th1 cells in susceptible mouse strains.

J D Peterson1, C Waltenbaugh, S D Miller.   

Abstract

Inbred mouse strains differ in susceptibility to Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. A strong correlation between disease susceptibility and delayed-type hypersensitivity (DTH) has been previously demonstrated, but no strong correlation between disease susceptibility and total anti-TMEV ELISA titres was shown. Since both DTH and IgG2a antibody production are regulated by CD4+ Th1 cells, we investigated three strains of mice to determine whether antivirus IgG2a antibody levels, like DTH in previous studies, correlated with disease susceptibility. Susceptible SJL/J, intermediately susceptible C3H/HeJ, and resistant C57BL/6 mice were infected intracerebrally (i.c.) with the BeAn strain of TMEV and monitored for clinical signs of demyelination and for levels of TMEV-specific antibody of different IgG subclasses using a particle concentration fluorescence immunoassay (PCFIA). Resistant C57BL/6 mice were found to have significantly lower concentrations of total anti-TMEV antibody than susceptible SJL/J mice and intermediately susceptible C3H/HeJ mice show variable antibody responses. A predominance of anti-TMEV IgG2a (Th1 regulated) antibody was seen in susceptible and intermediately susceptible mice, whereas resistant mice displayed a predominant anti-TMEV IgG1 (Th2 regulated) response accompanied by a marked deficiency of IgG2a. In contrast, immunization of C57BL/6 mice with UV-inactivated TMEV in adjuvant revealed that this strain was not defective either in its ability to generate high levels of anti-TMEV antibody or in its ability to produce IgG2a antibody. These results suggest that the antivirus IgG subclass profile is dependent upon the immunization route, virus viability and/or the use of adjuvant and that the levels of antivirus subclasses may be predictive of disease susceptibility.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1350571      PMCID: PMC1384845     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  41 in total

1.  Immune complex deposits in the choroid plexus.

Authors:  P W Lampert; R S Garrett; M B Oldstone
Journal:  Birth Defects Orig Artic Ser       Date:  1978

Review 2.  T-cell responses and immunity to experimental infection with leishmania major.

Authors:  I Müller; T Pedrazzini; J P Farrell; J Louis
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

Review 3.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

4.  The role of T-cell subsets and cytokines in the regulation of infection.

Authors:  P Scott; S H Kaufmann
Journal:  Immunol Today       Date:  1991-10

Review 5.  Lymphokine control of in vivo immunoglobulin isotype selection.

Authors:  F D Finkelman; J Holmes; I M Katona; J F Urban; M P Beckmann; L S Park; K A Schooley; R L Coffman; T R Mosmann; W E Paul
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

6.  Long-lived reciprocal regulation of antigen-specific IgE and IgG2a responses in mice treated with glutaraldehyde-polymerized ovalbumin.

Authors:  K T Hayglass; R S Gieni; W P Stefura
Journal:  Immunology       Date:  1991-08       Impact factor: 7.397

7.  Theiler's virus-associated antigens on the surfaces of cultured glial cells.

Authors:  M Rodriguez; L M Siegel; D Hovanec-Burns; L Bologa; M C Graves
Journal:  Virology       Date:  1988-10       Impact factor: 3.616

8.  Primary demyelination in Theiler's virus infection. An ultrastructural study.

Authors:  M C Dal Canto; H L Lipton
Journal:  Lab Invest       Date:  1975-12       Impact factor: 5.662

9.  Evidence for mouse Th1- and Th2-like helper T cells in vivo. Selective reduction of Th1-like cells after total lymphoid irradiation.

Authors:  H Bass; T Mosmann; S Strober
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

10.  Coronavirus-JHM-induced demyelinating encephalomyelitis in rats. Analysis of the intrathecal immune response.

Authors:  R Dörries; S Schwender; H Wege; H Harms; R Watanabe; V ter Meulen
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

View more
  14 in total

1.  Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response.

Authors:  P J Lewis; L A Babiuk
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

2.  Th17-biased RORγt transgenic mice become susceptible to a viral model for multiple sclerosis.

Authors:  Nicholas E Martinez; Fumitaka Sato; Eiichiro Kawai; Seiichi Omura; Satoru Takahashi; Keigyou Yoh; Ikuo Tsunoda
Journal:  Brain Behav Immun       Date:  2014-07-18       Impact factor: 7.217

3.  Treatment of Theiler's virus-induced demyelinating disease with teriflunomide.

Authors:  Francesca Gilli; Libin Li; Darlene B Royce; Krista D DiSano; Andrew R Pachner
Journal:  J Neurovirol       Date:  2017-09-14       Impact factor: 2.643

Review 4.  Virus-induced immunopathology.

Authors:  B T Rouse
Journal:  Adv Virus Res       Date:  1996       Impact factor: 9.937

5.  Indirect regulation of CD4 T-cell responses by tumor necrosis factor receptors in an acute viral infection.

Authors:  Anju Singh; Marcel Wüthrich; Bruce Klein; M Suresh
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

6.  Major linear antibody epitopes and capsid proteins differentially induce protective immunity against Theiler's virus-induced demyelinating disease.

Authors:  H Yahikozawa; A Inoue; C S Koh; Y K Choe; B S Kim
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

7.  Transition from acute to persistent Theiler's virus infection requires active viral replication that drives proinflammatory cytokine expression and chronic demyelinating disease.

Authors:  Mark Trottier; Brian P Schlitt; Aisha Y Kung; Howard L Lipton
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

8.  In vivo administration of interleukin-2 protects susceptible mice from Theiler's virus persistence.

Authors:  E L Larsson-Sciard; S Dethlefs; M Brahic
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

9.  Analysis of antibody responses to predominant linear epitopes of Theiler's murine encephalomyelitis virus.

Authors:  A Inoue; Y K Choe; B S Kim
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

Review 10.  Experimental cerebral malaria: possible new mechanisms in the TNF-induced microvascular pathology.

Authors:  G E Grau; J N Lou
Journal:  Soz Praventivmed       Date:  1995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.